{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:08:32Z","timestamp":1789056512592,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virologica Sinica"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.virs.2026.07.006","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:27:38Z","timestamp":1784204858000},"page":"961-971","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pygenic acid A, a small-molecule PD-1\/SHP-2 inhibitor, enhances efficacy of therapeutic melanoma vaccines and prophylactic influenza vaccines"],"prefix":"10.1016","volume":"41","author":[{"given":"Yan","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyi","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2270-1900","authenticated-orcid":false,"given":"Honglin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2255-0391","authenticated-orcid":false,"given":"Lu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8283-7135","authenticated-orcid":false,"given":"Shibo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virs.2026.07.006_bib1","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/imr.12519","article-title":"LAG3(CD223) as a cancer immunotherapy target","volume":"276","author":"Andrews","year":"2017","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.virs.2026.07.006_bib2","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fimmu.2013.00114","article-title":"Mechanisms of action of adjuvants","volume":"4","author":"Awate","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virs.2026.07.006_bib3","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature04444","article-title":"Restoring function in exhausted CD8 T cells during chronic viral infection","volume":"439","author":"Barber","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.virs.2026.07.006_bib4","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/COC.0000000000000239","article-title":"CTLA-4 and PD-1 pathways: similarities, differences, and implications of their inhibition","volume":"39","author":"Buchbinder","year":"2016","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.virs.2026.07.006_bib5","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.immuni.2014.10.004","article-title":"T follicular helper cell differentiation, function, and roles in disease","volume":"41","author":"Crotty","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.virs.2026.07.006_bib6","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/s41419-025-07984-4","article-title":"Tigit in cancer: from mechanism of action to promising immunotherapeutic strategies","volume":"16","author":"Cui","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.virs.2026.07.006_bib7","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/infdis\/jiy103","article-title":"A universal influenza vaccine: the strategic plan for the national institute of allergy and infectious diseases","volume":"218","author":"Erbelding","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virs.2026.07.006_bib8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.it.2009.12.009","article-title":"The immunobiology of aluminium adjuvants: how do they really work?","volume":"31","author":"Exley","year":"2010","journal-title":"Trends Immunol."},{"key":"10.1016\/j.virs.2026.07.006_bib9","doi-asserted-by":"crossref","first-page":"980","DOI":"10.4049\/jimmunol.182.2.980","article-title":"PD-1 blockade in rhesus macaques: impact on chronic infection and prophylactic vaccination","volume":"182","author":"Finnefrock","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.virs.2026.07.006_bib10","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41577-021-00566-3","article-title":"Interferon-\u03b3: teammate or opponent in the tumour microenvironment?","volume":"22","author":"Gocher","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.virs.2026.07.006_bib11","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/ni.1877","article-title":"PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells","volume":"11","author":"Good-Jacobson","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.virs.2026.07.006_bib12","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1084\/jem.20071949","article-title":"Enhancing therapeutic vaccination by blocking PD-1-mediated inhibitory signals during chronic infection","volume":"205","author":"Ha","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.virs.2026.07.006_bib13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41568-024-00761-z","article-title":"Convergent inducers and effectors of T cell paralysis in the tumour microenvironment","volume":"25","author":"Hanahan","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.virs.2026.07.006_bib14","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/nmat3775","article-title":"Engineering synthetic vaccines using cues from natural immunity","volume":"12","author":"Irvine","year":"2013","journal-title":"Nat. Mater."},{"key":"10.1016\/j.virs.2026.07.006_bib15","first-page":"7022","article-title":"Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressure1","volume":"48","author":"Jain","year":"1988","journal-title":"Cancer Res."},{"key":"10.1016\/j.virs.2026.07.006_bib16","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.tips.2024.10.011","article-title":"Tiny but mighty: small molecules as vaccine adjuvants","volume":"45","author":"Joffe","year":"2024","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.virs.2026.07.006_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioelechem.2021.107831","article-title":"Mutational burden, MHC-I expression and immune infiltration as limiting factors for in situ vaccination by TNF\u03b1 and IL-12 gene electrotransfer","volume":"140","author":"Kamensek","year":"2021","journal-title":"Bioelectrochemistry"},{"key":"10.1016\/j.virs.2026.07.006_bib18","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/s41590-022-01254-7","article-title":"PD-1 blockade unblocks immune responses to vaccination","volume":"23","author":"Kedzierska","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.virs.2026.07.006_bib19","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and its ligands in tolerance and immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.virs.2026.07.006_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41572-018-0002-y","article-title":"Influenza","volume":"4","author":"Krammer","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.virs.2026.07.006_bib21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/08830185.2013.773326","article-title":"Particulate adjuvant and innate immunity: past achievements, present findings, and future prospects","volume":"32","author":"Kuroda","year":"2013","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.virs.2026.07.006_bib22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40425-018-0353-7","article-title":"Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events","volume":"6","author":"L\u00e4ubli","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.virs.2026.07.006_bib23","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11427-024-2706-2","article-title":"Blocking the pd-1 signal transduction by occupying the phosphorylated itsm recognition site of shp-2","volume":"68","author":"Li","year":"2025","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.virs.2026.07.006_bib24","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-022-00612-2","article-title":"A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs","volume":"32","author":"Liu","year":"2022","journal-title":"Cell Res."},{"key":"10.1016\/j.virs.2026.07.006_bib25","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1146\/annurev.iy.12.040194.001001","article-title":"Germinal centers","volume":"12","author":"MacLennan","year":"1994","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.virs.2026.07.006_bib26","article-title":"Synergistic activation of antitumor immunity by a particulate therapeutic vaccine","volume":"8","author":"Mai","year":"2021","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.virs.2026.07.006_bib27","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nri2510","article-title":"Towards an understanding of the adjuvant action of aluminium","volume":"9","author":"Marrack","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.virs.2026.07.006_bib28","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s40425-019-0724-8","article-title":"Intratumoral immunotherapy with TLR7\/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies","volume":"7","author":"Mullins","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.virs.2026.07.006_bib29","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3390\/vaccines11030559","article-title":"Enhancement of vaccine-induced T-cell responses by PD-L1 blockade in calves","volume":"11","author":"Okagawa","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virs.2026.07.006_bib30","article-title":"B16 as a mouse model for human melanoma","author":"Overwijk","year":"2001","journal-title":"Curr. Protoc. Im."},{"key":"10.1016\/j.virs.2026.07.006_bib31","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.virs.2023.01.003","article-title":"Allogeneic gene-edited HIV-specific CAR-T cells secreting PD-1 blocking scFv enhance specific cytotoxic activity against HIV Env+ cells in vivo","volume":"38","author":"Pan","year":"2023","journal-title":"Virol. Sin."},{"key":"10.1016\/j.virs.2026.07.006_bib32","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.virs.2026.07.006_bib33","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMra1703481","article-title":"Immune-related adverse events associated with immune checkpoint blockade","volume":"378","author":"Postow","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virs.2026.07.006_bib34","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41573-021-00163-y","article-title":"Emerging concepts in the science of vaccine adjuvants","volume":"20","author":"Pulendran","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.virs.2026.07.006_bib35","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/nm.3409","article-title":"Key roles of adjuvants in modern vaccines","volume":"19","author":"Reed","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.virs.2026.07.006_bib36","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nri.2017.108","article-title":"The diverse functions of the PD1 inhibitory pathway","volume":"18","author":"Sharpe","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.virs.2026.07.006_bib37","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.immuni.2018.06.012","article-title":"PD-1 controls follicular t helper cell positioning and function","volume":"49","author":"Shi","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.virs.2026.07.006_bib38","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/CJI.0b013e318210ed0e","article-title":"Enhancement of vaccine-induced primary and memory CD8(+) T-cell responses by soluble PD-1","volume":"34","author":"Song","year":"2011","journal-title":"J. Immunother."},{"key":"10.1016\/j.virs.2026.07.006_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2017.06.006","article-title":"Non-human primates as a model for understanding the mechanism of action of toll-like receptor-based vaccine adjuvants","volume":"47","author":"Thompson","year":"2017","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.virs.2026.07.006_bib40","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1073\/pnas.1416159112","article-title":"Antigen specificity can be irrelevant to immunocytokine efficacy and biodistribution","volume":"112","author":"Tzeng","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virs.2026.07.006_bib41","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1146\/annurev-immunol-020711-075032","article-title":"Germinal centers","volume":"30","author":"Victora","year":"2012","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.virs.2026.07.006_bib42","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.coi.2014.02.010","article-title":"Clonal and cellular dynamics in germinal centers","volume":"28","author":"Victora","year":"2014","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.virs.2026.07.006_bib43","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","article-title":"T cell exhaustion","volume":"12","author":"Wherry","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.virs.2026.07.006_bib44","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12943-023-01885-w","article-title":"Exploiting innate immunity for cancer immunotherapy","volume":"22","author":"Yi","year":"2023","journal-title":"Mol. Cancer"}],"container-title":["Virologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1995820X26001082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1995820X26001082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:37:19Z","timestamp":1789054639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1995820X26001082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1995820X26001082"],"URL":"https:\/\/doi.org\/10.1016\/j.virs.2026.07.006","relation":{},"ISSN":["1995-820X"],"issn-type":[{"value":"1995-820X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pygenic acid A, a small-molecule PD-1\/SHP-2 inhibitor, enhances efficacy of therapeutic melanoma vaccines and prophylactic influenza vaccines","name":"articletitle","label":"Article Title"},{"value":"Virologica Sinica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virs.2026.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}